Glancy Binkow & Goldberg LLP, Representing Shareholders ofZynex, Inc., Announces There Are 12 Days Remaining to Move for Appointment as Lead Plaintiff
* Reuters is not responsible for the content in this press release.
LOS ANGELES--(Business Wire)--
Glancy Binkow & Goldberg LLP announces that all persons or entities who
purchased or otherwise acquired the securities of Zynex, Inc. (OTCBB:ZYXI)
(formerly Zynex Medical Holdings, Inc.) between May 21, 2008 and March 31, 2009
(the "Class Period") have only 12 days until the June 8, 2009, deadline to move
the Court to serve as Lead Plaintiff in the securities fraud class action
lawsuit. The case filed by Glancy Binkow & Goldberg LLP, Manandik v. Zynex,
Inc., et al., No. 09-cv-00829-REB-KMT, has been assigned to the Honorable Robert
E. Blackburn, United States District Judge for the District of Colorado.
A copy of the Complaint is available from the court or from Glancy Binkow &
Goldberg LLP. Please contact us by phone to discuss this action or to obtain a
copy of the Complaint at 310-201-9150 or Toll Free at 888-773-9224, by email at
info@glancylaw.com, or visit our website at http://www.glancylaw.com.
The Complaint charges Zynex and certain of the Company's executive officers with
violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934
and S.E.C. Rule 10b-5, and further alleges that throughout the Class Period
defendants knew or recklessly disregarded that their public statements
concerning the Company's financial performance were materially false and
misleading.
The Private Securities Litigation Reform Act of 1995 ("PSLRA") requires the
Court to appoint a "Lead Plaintiff" in this case. Any person or group who
purchased Zynex securities during the Class Period and suffered a loss may ask
the Court to be appointed as Lead Plaintiff, but must file a motion no later
than the June 8, 2009 deadline.
Glancy Binkow & Goldberg LLP is a law firm with significant experience in
prosecuting class actions, substantial expertise in actions involving corporate
fraud, and is representing shareholders of Zynex in this litigation.
If you wish to discuss this action or have any questions concerning this Notice
or your rights or interests with respect to these matters, please contact
Michael Goldberg, Esquire, or Richard A. Maniskas, Esquire, of Glancy Binkow &
Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, California
90067, by telephone at 310-201-9150 or Toll Free at 888-773-9224 or by e-mail to
info@glancylaw.com.
Glancy Binkow & Goldberg LLP
Lionel Z. Glancy
Michael Goldberg
Richard A. Maniskas
310-201-9150 or 888-773-9224
info@glancylaw.com
www.glancylaw.com
Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters